Having trouble viewing this email? View it as a Web page.
|
Thursday, August 04, 2016 The following funding information has been recently added to the CDC National Prevention Information Network's (NPIN) Funding Database (http://npin.cdc.gov/search/funding). |
|
Fund Number: 5170 - Fund Title: Mechanisms of Immune Activation and Inflammation: HIV Infection, ART, and Drugs of Abuse (R01)
|
Fund Number: 5170
Fund Title: Mechanisms of Immune Activation and Inflammation: HIV Infection, ART, and Drugs of Abuse (R01)
Fund Category: HIV/AIDS
Description: The purpose of this FOA is to promote research to investigate the underlying molecular mechanisms of HIV infection-induced immune activation and inflammation in the presence of antiretroviral therapy (ART) agents and drugs of abuse. The ultimate goal is to obtain information for developing therapeutic interventions for attenuating chronic inflammation-associated comorbidities as well as for restoring or improving ART efficacy in HIV-infected drug-abusing populations.
Sponsor(s): US Department of Health and Human Services National Institutes of Health
Funder's Fund ID: RFA-DA-17-013
Web Page: grants.nih.gov/grants/guide/rfa-files/RFA-DA-17-013.html
Letter of Intent Date: 10/28/2016
Application Due Date: 11/18/2016
Fund Duration: The maximum project period is 5 years.
Application Process: It is critical that applicants follow the instructions in the Research Instructions for the SF424 (R&R) Application Guide, including Supplemental Grant Application Instructions except where instructed in the funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
Number of Awards: 4-5 grants
Award Notes: NIDA intends to fund an estimate of 4 - 5 grant awards, corresponding to a total of $3M for fiscal year 2017. Future year amounts will depend on annual appropriations.
Eligible Locations: - National
Application Contact Name: Vishnudutt Purohit Application Contact Address: United States Email: vpurohit@nida.nih.gov Phone: 301-594-5753
Technical Contact Name: Mark Swieter, Ph.D. Technical Contact Address: United States Email: mswieter@mail.nih.gov Phone: 301-435-1389
Contact Note: For additional agency contacts, please see complete FOA.
Support Types: - Awards/Prizes/Competitions
Subject Areas: - Antiretroviral Drugs - Clinical Research - HIV
Audiences: - Researchers
Eligibility: - City Agencies - Community Based Organizations - County Agencies - IRS 501 (c)(3) Organizations - Nonprofit Organizations - Public Education Departments - State Agencies - Tribal Organizations
Eligibility Notes: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs); U.S. Territory or Possession.
Back to Top |
|
NPIN provides the Funding Announcements Update electronic mailing list as a public service only. Listings come from federal government agencies and private organizations that fund HIV/AIDS, viral hepatitis, STD, and TB prevention work. Inclusion does not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. For more information on a specific funding opportunity, please contact the funder. If you have information about your organization's funding opportunities that you would like included in the NPIN databases and/or in the e-mail announcements, please send it via e-mail to npin-info@cdc.gov. **This message may be copied and distributed; however, it may not be distributed for profit.** |
Postingan terkait:
Belum ada tanggapan untuk "Funding Information for HIV/Hepatitis/STD/TB 8/04/2016"
Post a Comment